Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)

Background: Treatment outcomes are poorly characterized in patients with metastatic chromophobe renal cell cancer (chrRCC), a subtype of renal cell carcinoma. Objective: This retrospective series aims to determine metastatic chrRCC treatment outcomes in the targeted therapy era. Methods: A retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Yip, Steven M., Ruiz Morales, Jose M., Donskov, Frede, Fraccon, Anna, Basso, Umberto, Rini, Brian I., Lee, Jae Lyun, Bjarnason, Georg A., Sim, Hao-Wen, Beuselinck, Benoit, Kanesvaran, Ravindran, Brugarolas, James, Koutsoukos, Kostas, Fu, Simon Yuen Fai, Yuasa, Takeshi, Davis, Ian, Alva, Ajjai, Kollmannsberger, Christian, Choueiri, Toni K., Heng, Daniel Y.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2017
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179119/
https://www.ncbi.nlm.nih.gov/pubmed/30334003
http://dx.doi.org/10.3233/KCA-160002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179119/
https://www.ncbi.nlm.nih.gov/pubmed/30334003
http://dx.doi.org/10.3233/KCA-160002

Ejemplares similares